An EGF receptor inhibitor induces RAR-β expression in breast and ovarian cancer cells

被引:22
作者
Grunt, TW [1 ]
Puckmair, K
Tomek, K
Kainz, B
Gaiger, A
机构
[1] Med Univ Vienna, Dept Med 1, Div Oncol, Signaling Networks Program, Vienna, Austria
[2] Med Univ Vienna, Dept Med 1, Div Hematol & Hemostaseol, Vienna, Austria
关键词
cross-talk; EGER inhibitor; ErbB receptors; RAR-beta; retinoid receptors;
D O I
10.1016/j.bbrc.2005.02.104
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of the epidermal growth factor (EGF)-receptor (EGFR) has become a promising anticancer treatment strategy. In addition, application of retinoids yields encouraging results for cancer prevention and therapy. Many tumors express no or low amounts of retinoic acid receptor-beta 2 (RAR-beta 2) due to epigenetic silencing via DNA hypermethylation. RAR-beta 2 is the main mediator of the antiproliferative effect of retinoids. RAR-beta 2 re-expression causes reversal of transformation, cell cycle arrest, and restoration of retinoid sensitivity. RAR-beta 2 is thus a tumor suppressor. Western blotting, colorimetric in vitro cell proliferation assays, and reverse transcription-polymerase chain reaction demonstrated that the EGFR inhibitor PD153035 not only blocked activation of EGFR and inhibited cell growth. but also stimulated RAR-beta expression in MDA-MB-468 breast and OVCAR-3 ovarian carcinoma cells. Upregulation of RAR-beta by PD153035 was confirmed by real-time reverse transcription-polymerase chain reaction. In contrast, expression of other retinoid receptors and of estrogen receptor-alpha was not affected. PD153035-mediated re-induction of RAR-beta was associated with demethylation of the RAR-beta 2 gene promoter beta 2 as demonstrated by methylation-specific polymerase chain reaction. These novel results on the ErbB/retinoid receptor cross-talk may be useful for designing future anticancer combination regimens. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1253 / 1259
页数:7
相关论文
共 50 条
[21]   Nucleo-cytoplasmic transport of estrogen receptor alpha in breast cancer cells [J].
Tecalco-Cruz, Angeles C. ;
Perez-Alvarado, Issis A. ;
Ramirez-Jarquin, Josue O. ;
Rocha-Zavaleta, Leticia .
CELLULAR SIGNALLING, 2017, 34 :121-132
[22]   Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer Cells [J].
Liu, Chun-Yu ;
Chu, Pei-Yi ;
Huang, Chun-Teng ;
Chen, Ji-Lin ;
Yang, Hsiu-Ping ;
Wang, Wan-Lun ;
Lau, Ka-Yi ;
Lee, Chia-Han ;
Lan, Tien-Yun ;
Huang, Tzu-Ting ;
Lin, Po-Han ;
Dai, Ming-Shen ;
Tseng, Ling-Ming .
CANCERS, 2019, 11 (01)
[23]   Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species [J].
Verdoodt, Berlinda ;
Vogt, Markus ;
Schmitz, Inge ;
Liffers, Sven-Thorsten ;
Tannapfel, Andrea ;
Mirmohammadsadegh, Alireza .
PLOS ONE, 2012, 7 (09)
[24]   Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells [J].
Rasmussen, Louise Maymann ;
Frederiksen, Klaus Stensgaard ;
Din, Nanni ;
Galsgaard, Elisabeth ;
Christensen, Leif ;
Berchtold, Martin Werner ;
Panina, Svetlana .
ENDOCRINE-RELATED CANCER, 2010, 17 (03) :809-822
[25]   Clinical Significance of Tumor Infiltrating Lymphocytes in Association with Hormone Receptor Expression Patterns in Epithelial Ovarian Cancer [J].
Han, Gwan Hee ;
Hwang, Ilseon ;
Cho, Hanbyoul ;
Ylaya, Kris ;
Choi, Jung-A ;
Kwon, Hyunja ;
Chung, Joon-Yong ;
Hewitt, Stephen M. ;
Kim, Jae-Hoon .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
[26]   The cytotoxicity of γ-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by γ-secretase inhibition [J].
Han, Jianxun ;
Ma, Ivy ;
Hendzel, Michael J. ;
Allalunis-Turner, Joan .
BREAST CANCER RESEARCH, 2009, 11 (04)
[27]   Retinoic Acid Sensitivity of Triple-Negative Breast Cancer Cells Characterized by Constitutive Activation of the notch1 Pathway: The Role of Rarβ [J].
Paroni, Gabriela ;
Zanetti, Adriana ;
Barzago, Maria Monica ;
Kurosaki, Mami ;
Guarrera, Luca ;
Fratelli, Maddalena ;
Troiani, Martina ;
Ubezio, Paolo ;
Bolis, Marco ;
Vallerga, Arianna ;
Biancardi, Federica ;
Terao, Mineko ;
Garattini, Enrico .
CANCERS, 2020, 12 (10) :1-23
[28]   Crosstalk between estrogen receptor α and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes [J].
Wormke, M ;
Stoner, M ;
Saville, B ;
Safe, S .
FEBS LETTERS, 2000, 478 (1-2) :109-112
[29]   Blockade of the Hedgehog pathway downregulates estrogen receptor alpha signaling in breast cancer cells [J].
Diao, Yumei ;
Azatyan, Ani ;
Rahman, Mohammed Ferdous-Ur ;
Zhao, Chunyan ;
Zhu, Jian ;
Dahlman-Wright, Karin ;
Zaphiropoulos, Peter G. .
ONCOTARGET, 2016, 7 (44) :71580-71593
[30]   A psychiatric medication, clozapine, induces autophagy and apoptosis in breast cancer cells through reactive oxygen species [J].
Fan, Ya-Chun ;
Lin, Shih-Chao ;
Lai, Po-Jung ;
Lai, Pei-Chun ;
Maurus, Germain ;
Chen, Shiow-Yi .
PLOS ONE, 2025, 20 (06)